Dr. Laneshia Tague has received a KL2 award with a July 1st, 2019 appointment start. The grant title is “Pharmacogenetic-based Mycophenolate Dosing to Improve Lung Transplant Outcomes”.
Dr. Laneshia Tague Receives KL2 Award
Dr. Laneshia Tague has received a KL2 award with a July 1st, 2019 appointment start. The grant title is “Pharmacogenetic-based Mycophenolate Dosing to Improve Lung Transplant Outcomes”.